Galaxy Medicare Limited IPO

Apply 0
Avoid 0

Galaxy Medicare Limited was incorporated on July 23, 1992 in Bhubaneswar, Odisha, as a public limited company under the Companies Act, 1956. Founded by Mr. Dillip Kumar Das, the company commenced operations by reviving a closed unit acquired from IDCO and Odisha State Financial Corporation under IPICOL’s investment promotion strategy.

Business Activities

The company is engaged in manufacturing, trading, and exporting of medical devices and surgical dressings. Its key operations include:

1. Manufacturing & Branding under flagship brands like POP BAND, POP CAST, G CAST, GYPSOSOFT, CARETAPE, CARECREPE, CAREPORE, GYPSONET, FIXCAN, etc.

2. OEM Services – sourcing, designing, manufacturing, and testing for other brand owners.

3. Institutional Sales – supplying to government departments via tenders and GEM portal.

4. Exports – catering to international markets such as Bangladesh and Nepal.

5. Domestic Trading of medical devices and surgical products.

Products & Trademarks

Company specializes in Plaster of Paris Bandages (POP Bandage), medical tapes, surgical dressings, and a wide range of wound care and wound management products. The company holds 27 registered trademarks in India under various brand names, reflecting its strong market presence. Its products are widely supplied to Central and State Government Health Departments, Corporate Hospitals, and private healthcare providers across India, ensuring extensive reach and reliability.

Market Presence

Galaxy Medicare Limited enjoys a strong domestic presence with well-established client relationships across India. The company has also built a growing export network in Bangladesh, Nepal, and other international markets, further strengthening its global footprint. Recognized by the medical fraternity for its innovation and quality, Galaxy Medicare continues to be a trusted name in the field of medical devices and surgical dressings.

Competitive Strengths

i) Experienced leadership and skilled management team.
ii) Strong reputation and long-term customer relationships.
iii) Global presence with wide product acceptance.
iv) Well-established manufacturing facility catering to diverse medical products.
v) Robust in-house R&D, QA, and QC functions to ensure product effectiveness and safety.

Objects of the Galaxy Medicare Limited IPO:

Company proposes to utilize the Net Proceeds of fresh issue to meet the following objects: 1. Funding Capital Expenditure requirement towards purchase of machinery (₹4.88 cr) 2. Funding the working capital requirements (₹9.97 cr) 3. General Corporate Purpose 4. To meet the Offer expenses

Galaxy Medicare Limited IPO Details:

Open Date: Sep 10 2025
Close Date: Sep 12 2025
Total Shares: 41,32,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 22.31 Cr.
Lot Size: 2000 Shares
Issue Price: ₹ 51-54 Per Equity Share
Listing At: NSE Emerge
Listing Date: Sep 17 2025

Promoters And Management:

1. Mr. Dillip Kumar Das – Promoter, Chairman & Managing Director, a Fellow of the Institution of Engineers (India) and B.Sc. (Electrical Engineering), he has over two decades of industry experience. Awarded by the MSME Ministry in 2010 for outstanding entrepreneurship, he leads strategic planning, business development, finance, and overall operations, driving growth through innovation, client development, and strong leadership. 2. Mrs. Kiran Das – Promoter & Whole-Time Director, holds a B.A. (Hons) in Political Science. With 5+ years at the company, she oversees administration, production planning, R&D, design and development of medical devices, quality assurance, and daily operations. Known for her organizational skills and detail-oriented approach, she ensures smooth functioning of the company. 3. Mr. Subhasish Das – Promoter & Whole-Time Director, holds a PGDM from XIM Bhubaneswar. He received the MSME National Award for Outstanding Entrepreneurship in 2011. With over a decade of experience, he heads sales, marketing, business development, and supply chain, bringing strong customer relations, strategic thinking, and execution capabilities to expand the company’s market reach.

Financials of Galaxy Medicare Limited IPO:

Particulars FY2024-2025 FY 2023-2024 FY 2022-2023
Revenue from Operations 39.20 36.15 31.20
EBITDA 4.58 5.26 3.13
EBITDA Margins 11.69% 14.56% 10.05%
PAT 3.37 3.7 1.57
PAT Margins 8.59% 10.23% 5.03%
ROCE 22.38% 25.17% 14.08%
Debt to Equity Ratio(In Times) 0.25 0.52 0.77
Operating Cash Flows 4.48 2.7 3.65

Comparison With Peers:

Companies Revenue (in cr) EBITDA Margins PAT Margins ROCE D/E Ratio MCap (in cr) P/E
Galaxy Medicare 39.20 11.69% 8.59% 22.38% 0.25 81.92 24.31
Adeshwar Meditex Limited 83.71 5.28% 2.47% 8.27% 0.34 26 13.1
KMS Medisurgi Limited 13.9 7% 3.16% 8.02% 0.11 41.8 94.9

Lead Manager of Galaxy Medicare Limited IPO:

  1. Affinity Global Capital Markets Pvt Ltd

Registrar of Galaxy Medicare Limited IPO:

  1. Cameo Corporate Services Limited

Discussion on Galaxy Medicare Limited IPO:

Leave a Reply